WHAT’S ON

News

The Research Institute de Sant Pau Foundation joins the IRISCAT Alliance

The Foundation of the Research Institute of the Hospital de la Santa Creu i Sant Pau joins the Aliança Instituts de Recerca i Innovació en salut de Catalunya (IRISCAT). The main objectives of this a...

Exheus, a new spin-off that analyzes gene expression, using artificial intelligence, to optimize performance, health and nutrition

Exheus is a recent spin-off born thanks to the research carried out by the Sant Pau Research Institute, the Polytechnic University of Catalonia - BarcelonaTech (UPC) and the company Summit SL, which h...

Sant Pau researchers discover a mutation that increases the risk of breast cancer almost fourfold

Geneticists from the Research Institute of the Hospital de Sant Pau - IIB Sant Pau and the IFOM - Instituto FIRC di Oncologia Molecolare of Milan (Italy), led by doctors Jordi Surrallés and Paolo Pet...

CERCA centres for gender equality

  The CERCA system is committed to the equality of people and the maximum respect for their different situations and wants to improve the current situation for people and research institutions...

Sant Pau leads the way in the creation of a new nanodrug that blocks the tumour cells of acute myeloid leukaemia without damaging healthy ones

Acute myeloid leukemia is a very heterogeneous disease, the usual treatment is very aggressive and with severe side effects. In the investigation of a new, more effective drug, researchers led by the ...

1 74 75 76 77 78 120

This website uses cookies to improve the browsing experience and perform analytical tasks. If you continue browsing, we understand that you agree our cookies policy. More information